Medicare Reform Should Not Undercut Local Coverage Process – Medtronic
This article was originally published in The Gray Sheet
HHS should ensure that Medicare reform efforts to consolidate claims processing do not erode the autonomy of carrier medical directors to make local coverage decisions, Medtronic maintains in March 5 comments to the HHS Secretary's Advisory Committee on Regulatory Reform
You may also be interested in...
Patients with urinary incontinence treated with sacral nerve stimulation (SNS) must keep a voiding diary to assess the therapy's effectiveness, according to a national Medicare coverage determination issued by CMS (formerly HCFA) on June 29.
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.